Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr;56(4):3038-3052.
doi: 10.1007/s12035-018-1288-1. Epub 2018 Aug 7.

Selective Knockdown of TASK3 Potassium Channel in Monoamine Neurons: a New Therapeutic Approach for Depression

M Neus Fullana  1   2   3 , Albert Ferrés-Coy  1   2   3 , Jorge E Ortega  3   4 , Esther Ruiz-Bronchal  1   2   3 , Verónica Paz  1   2   3 , J Javier Meana  3   4 , Francesc Artigas  1   2   3 , Analia Bortolozzi  5   6   7
Affiliations
Free article

Selective Knockdown of TASK3 Potassium Channel in Monoamine Neurons: a New Therapeutic Approach for Depression

M Neus Fullana et al. Mol Neurobiol. 2019 Apr.
Free article

Abstract

Current pharmacological treatments for major depressive disorder (MDD) are severely compromised by both slow action and limited efficacy. RNAi strategies have been used to evoke antidepressant-like effects faster than classical drugs. Using small interfering RNA (siRNA), we herein show that TASK3 potassium channel knockdown in monoamine neurons induces antidepressant-like responses in mice. TASK3-siRNAs were conjugated to cell-specific ligands, sertraline (Ser) or reboxetine (Reb), to promote their selective accumulation in serotonin (5-HT) and norepinephrine (NE) neurons, respectively, after intranasal delivery. Following neuronal internalization of conjugated TASK3-siRNAs, reduced TASK3 mRNA and protein levels were found in the brainstem 5-HT and NE cell groups. Moreover, Ser-TASK3-siRNA induced robust antidepressant-like behaviors, enhanced the hippocampal plasticity, and potentiated the fluoxetine-induced increase on extracellular 5-HT. Similar responses, yet of lower magnitude, were detected for Reb-TASK3-siRNA. These findings provide substantial support for TASK3 as a potential target, and RNAi-based strategies as a novel therapeutic approach to treat MDD.

Keywords: Depression; Intranasal delivery; K2P channel; New antidepressant target; RNAi.

PubMed Disclaimer

References

    1. Eur J Pharmacol. 1999 Aug 20;379(1):53-7 - PubMed
    1. J Biol Chem. 2000 Jun 2;275(22):16650-7 - PubMed
    1. Biol Psychiatry. 2000 May 1;47(9):818-29 - PubMed
    1. Brain Res Mol Brain Res. 2001 Jan 31;86(1-2):101-14 - PubMed
    1. Neuropharmacology. 2001 Mar;40(4):551-9 - PubMed

MeSH terms